Correlation Between Blueprint Medicines and Agios Pharm
Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and Agios Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and Agios Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blueprint Medicines Corp and Agios Pharm, you can compare the effects of market volatilities on Blueprint Medicines and Agios Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of Agios Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and Agios Pharm.
Diversification Opportunities for Blueprint Medicines and Agios Pharm
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Blueprint and Agios is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and Agios Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agios Pharm and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with Agios Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agios Pharm has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and Agios Pharm go up and down completely randomly.
Pair Corralation between Blueprint Medicines and Agios Pharm
Given the investment horizon of 90 days Blueprint Medicines is expected to generate 1.74 times less return on investment than Agios Pharm. But when comparing it to its historical volatility, Blueprint Medicines Corp is 1.19 times less risky than Agios Pharm. It trades about 0.2 of its potential returns per unit of risk. Agios Pharm is currently generating about 0.29 of returns per unit of risk over similar time horizon. If you would invest 4,608 in Agios Pharm on August 28, 2024 and sell it today you would earn a total of 1,143 from holding Agios Pharm or generate 24.8% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Blueprint Medicines Corp vs. Agios Pharm
Performance |
| Timeline |
| Blueprint Medicines Corp |
| Agios Pharm |
Blueprint Medicines and Agios Pharm Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Blueprint Medicines and Agios Pharm
The main advantage of trading using opposite Blueprint Medicines and Agios Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, Agios Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agios Pharm will offset losses from the drop in Agios Pharm's long position.| Blueprint Medicines vs. Eliem Therapeutics | Blueprint Medicines vs. HCW Biologics | Blueprint Medicines vs. Scpharmaceuticals | Blueprint Medicines vs. Milestone Pharmaceuticals |
| Agios Pharm vs. Mereo BioPharma Group | Agios Pharm vs. Blueprint Medicines Corp | Agios Pharm vs. Day One Biopharmaceuticals | Agios Pharm vs. Biomarin Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |